Home » Topics » BioWorld Science

BioWorld Science
RSS

Rigel and Novartis begin collaboration to discover antiangiogenic agents

Aug. 8, 2001

Endorex acquires CTD and adds two clinical-stage products to its pipeline

Aug. 8, 2001

FDA grants fast track status to TransMID-107R for the treatment of brain cancer

Aug. 8, 2001

Novasite Pharmaceuticals and Aventis enter evaluation agreement

Aug. 8, 2001

Genzyme receives marketing authorization for Fabrazyme

Aug. 8, 2001

Questcor sells shares of common stock to Sigma-Tau

Aug. 8, 2001

Noven signs product development agreement with Novartis for combination HRT patches

Aug. 8, 2001

First kidney transplant patient enrolled in phase II trials of ISAtx-247

Aug. 8, 2001

Cell Genesys expands oncology pipeline with acquisition of Calydon

Aug. 8, 2001

Novartis files Estradot in the European Union

Aug. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...